N(2)-dansyl-L-arginine-4-t-butylpiperidine amide: intereacts with Ca(2+)-regulated modulator protein; inhibits Ca(2+)-dependent protein kinase (myosin light chain kinase) and Ca(2+)-dependent ATPase of chicken gizzard actomyosin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 173248 |
MeSH ID | M0083819 |
Synonym |
---|
ti 233 |
2-[(4s)-5-(4-tert-butylpiperidin-1-yl)-4-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]-5-oxopentyl]guanidine |
n(2)-dansyl-l-arginine-4-t-butylpiperidine amide |
4-tert-butyl-1-(n(2)-(5-dimethylaminonaphthalene)-1-sulfonyl-l-arginyl)piperidine |
no 233 |
4-isopropyl-1-(n(2)-(5,6-dimethylaminonaphthalene)-1-sulfonyl-l-arginyl)piperidine |
piperidine, 1-(5-((aminoiminomethyl)amino)-2-(((5-(dimethylamino)-1-naphthalenyl)sulfonyl)amino)-1-oxopentyl)-4-(1,1-dimethylethyl)-, (s)-, diacetate |
piperidine, 1-(5-((aminoiminomethyl)amino)-2-(((5-(dimethylamino)-1-naphthalenyl)sulfonyl)amino)-1-oxopentyl)-4-(1,1-dimethylethyl)-, (s)- |
74133-53-2 |
DTXSID60225095 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 8 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.25) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |